azomycin has been researched along with acid phosphatase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barratt, GM; Wills, ED | 1 |
| Agler, ML; Chen, T; Dickson, JK; Feyen, JH; Huang, J; Knapp, AC; Lawrence, RM; Lynch, JS; Wu, Y | 1 |
2 other study(ies) available for azomycin and acid phosphatase
| Article | Year |
|---|---|
Effects of misonidazole, irradiation and hyperthermia on lysosomal enzyme activity in mouse tumours.
Topics: Acid Phosphatase; Animals; Body Temperature; Cell Membrane Permeability; Glucuronidase; Hot Temperature; Lysosomes; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Time Factors | 1981 |
High throughput screening identified a substituted imidazole as a novel RANK pathway-selective osteoclastogenesis inhibitor.
Topics: Acid Phosphatase; Animals; Cell Line; Cell Line, Tumor; Cell Survival; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression; Humans; Imidazoles; Isoenzymes; Lipopolysaccharides; Luciferases; Nitroimidazoles; Osteoclasts; Osteoprotegerin; Pyridines; RANK Ligand; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tartrate-Resistant Acid Phosphatase; Tumor Necrosis Factor-alpha | 2006 |